189
Participants
Start Date
April 2, 2021
Primary Completion Date
March 3, 2025
Study Completion Date
June 30, 2026
evorpacept
IV Q3W
pembrolizumab
IV Q3W
VUMC Goederenontvangst, Amsterdam
Cliniques Universitaires Saint-Luc, Brussels
St. Vincent's, Sydney
Peter MacCallum Cancer Centre, Melbourne
Severance Hospital Yonsei University, Seoul
Royal Brisbane and Womens Hospital, Brisbane
Ashford Cancer Centre Research, Windsor Gardens
Sir Charles Gairdner Hospital, Perth
AZ Groeninge, Kortrijk
Universitair Medisch Centrum Groningen, Groningen
Memorial Sloan-Kettering Cancer Center, Long Island City
CHA University of Bundang, Gyeonggi-do
Seoul National University Bundang Hospital, Seongnam
Catholic University of Korea, St. Vincent's Hospital Suwon, Suwon
University of Maryland Medical System, Baltimore
Gachon University - Gil Medical Center, Incheon
Yonsei University - Wonju Severance Christian Hospital, Wŏnju
Hospital Universitario La Paz, Madrid
HM Sanchinarro, Madrid
Chungbuk National University Hospital, Cheongju-si
Hospital Severo Ochoa, Madrid
Hospital Regional Universitario de Malaga, Málaga
Northwest Georgia Oncology Centers, Marietta
Hospital Universitario de Navarra, Pamplona
H. Lee Moffitt Cancer Center, Tampa
Chungnam National University Hospital, Daejeon
Vanderbilt - Ingram Cancer Center, Nashville
Yeungnam University Medical Center, Daegu
The Ohio State University, Columbus
Rush University Medical Center, Chicago
Blessing Cancer Center, Quincy
Houston Methodist Cancer Center, Houston
University of California San Diego, La Jolla
Hoag Hospital, Irvine
Oregon Health & Science University, Portland
National University Cancer Institute, Singapore
National Cancer Centre Singapore, Singapore
Massachusetts General Hospital, Boston
Rutgers Cancer Institute of New Jersey, Newark
UZ Leuven, Leuven
Hamilton Health Sciences - Juravinski Cancer Centre, Hamilton
LHSC - Victoria Hospital, London
Ottawa Hospital Cancer Centre, Ottawa
Princess Margaret Cancer Centre, Toronto
Korea University Medical Center (KUMC) - Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
The Catholic University of Korea - Eunpyeong St. Mary's Hospital, Seoul
Samsung Medical Center, Seoul
SNU Boramae Medical Center, Seoul
Hospital Universitari Dexeus, Barcelona
Institud Catala d´Oncologia, Barcelona
Royal Marsden NHS Foundation Trust, London
Royal Marsden NHS Foundation Trust, Sutton
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
ALX Oncology Inc.
INDUSTRY